Pharmaceutical Giant Raises Full-Year Guidance Amid 13% Earnings Surge
GSK Raises Full-Year Guidance Following 13% Earnings Increase.
Disclaimer: This article is for informational purposes only and should not be construed as financial or investment advice. The contents herein reflect the latest available information at the time of writing.
Real-time information is available daily at https://stockregion.net